Rheumatoid Factor Less Than 10 IU/mL: Clinical Significance and Diagnostic Implications

Clinical Significance of Negative RF

The American College of Rheumatology (ACR) and European League Against Rheumatism (EULAR) classification criteria categorize RF values less than or equal to the upper limit of normal (typically ≤14-15 IU/mL) as negative 1
A negative RF result (less than 10) contributes 0 points to the diagnostic scoring system for rheumatoid arthritis in the 2010 ACR/EULAR classification criteria 2

RF should always be interpreted alongside other clinical findings and laboratory tests, particularly anti-citrullinated protein antibody (ACPA) status 1
In the 2010 ACR/EULAR classification criteria for RA, serology (RF and ACPA) can contribute up to 3 points in the scoring system, with a score of ≥6/10 needed for definite classification 2, 3
The scoring system categorizes serological findings as:
- Negative RF and negative ACPA = 0 points 3
- Low positive RF or low positive ACPA = 2 points 3
- High positive RF or high positive ACPA = 3 points 2

A negative RF should prompt consideration of other causes of joint symptoms, including other inflammatory arthritides (psoriatic arthritis, ankylosing spondylitis) 2
A negative RF should also prompt consideration of osteoarthritis 2
A negative RF should also prompt consideration of crystal arthropathies (gout, pseudogout) 2
A negative RF should also prompt consideration of viral or reactive arthritis 3

If clinical suspicion for RA remains high despite negative RF, additional testing and close monitoring are warranted 3
Advanced imaging techniques such as ultrasound or MRI may detect subclinical synovitis in patients with negative RF but suspected RA 3
Repeat RF testing may be considered in patients with evolving symptoms, as seroconversion can occur over time 3

Poor specimen collection and handling can result in false negative results, according to the British Medical Journal, with incorrect transport of specimens also affecting test accuracy 4, 5
Testing performed too early in the disease course before antibody development can lead to false negative results, as reported by the British Medical Journal 4, 5

Patients on immunosuppressive therapy may have falsely negative RF results due to suppressed antibody production, as noted by the American College of Rheumatology in Arthritis Care & Research 6
Consider repeating screening tests when immunosuppression makes false negatives more likely, as recommended by the American College of Rheumatology in Arthritis Care & Research 6

Psoriatic arthritis commonly presents with negative RF, according to the Mayo Clinic Proceedings, with ankylosing spondylitis and other spondyloarthropathies also being RF-negative 7, 8
Radiographic evidence of erosive changes typical of RA can be an important diagnostic consideration, as reported by the Mayo Clinic Proceedings 7

Repeat RF testing may be warranted in patients with evolving symptoms, as seroconversion can occur over time, as noted by Clinical Infectious Diseases 9
Expert rheumatologist consultation is recommended when differential diagnoses are unclear, according to the Mayo Clinic Proceedings 7, 8

Immunocompromised patients, including those with renal failure or cryoglobulinemia, can have false negative serologic results, according to the American Society of Transplantation 10
Patients on immunosuppressive therapy may produce falsely negative RF results due to suppressed antibody production, a critical consideration in transplant recipients, patients on corticosteroids, or those receiving other immunosuppressive medications, as noted by the American Society of Transplantation 10